Some studies have found a high frequency of VUS in HRR genes in ovarian cancer patients, but they have also shown that two decades of testing and research on BRCA1 and BRCA2 have led to a significant decrease in VUS rates in BRCA, which are lower than in most other genes [83]. The gene discussed is BRCA2; the disease is ovarian carcinoma.